NPS Pharmaceuticals, Inc. (NPSP) Tops Q2 EPS by 2c
Tweet Send to a FriendGet Alerts NPSP Hot Sheet
Price: $15.33 +2.89%
Revenue Growth %: +14.5%
Financial Fact:
Diluted shares: 88.4M
Today's EPS Names:
CO, JW-A, FDS, More
Revenue Growth %: +14.5%
Financial Fact:
Diluted shares: 88.4M
Today's EPS Names:
CO, JW-A, FDS, More
Trade NPSP Now!
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q2 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $27.21 million versus the consensus estimate of $24.46 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Initial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional Symptoms
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
- Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients with Hypoparathyroidism
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
